-
AI-10-49 Workflows for inv(16) AML Research
2026-08-28
AI-10-49 enables mechanism-led interrogation of the CBFβ-SMMHC/RUNX1 axis, linking fusion-protein disruption to chromatin, transcriptional, and survival readouts. This practical guide covers dose finding, target-engagement assays, chromatin immunoprecipitation, MYCN/eIF4G1 analysis, and in vivo leukemia model design.
-
VX-745 for Reproducible Cell Assays
2026-08-27
Learn how VX-745, SKU A8686, can help researchers interpret viability, proliferation, and inflammatory readouts through selective p38α MAPK inhibition. This scenario-based guide covers assay compatibility, dosing, controls, data interpretation, and practical product-selection criteria.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-08-27
The reference study identifies MDM1 as a regulator of p53 expression and apoptosis that influences colorectal cancer sensitivity to chemoradiotherapy. Its combination of genetic perturbation, RNA sequencing, mechanistic promoter analysis, and xenograft testing supports MDM1 as a candidate predictive biomarker, while also suggesting that apoptosis-directed interventions may help investigate treatment resistance.
-
Diuron: Mechanism, Renal Toxicology & Workflow
2026-08-26
Diuron, also known as 3-(3,4-dichlorophenyl)-1,1-dimethylurea, is a phenylurea photosynthesis inhibitor used in plant biology research and toxicology. Current evidence links experimental Diuron exposure to JAK2/STAT1 pathway activation and acute kidney injury phenotypes in an integrated network-toxicology and HK-2-cell study.
-
MitMAB for Organoid Endocytosis Research
2026-08-26
MitMAB enables mechanism-focused testing of dynamin-dependent vesicle scission in intestinal organoid and extracellular-vesicle uptake assays. This guide translates recent intestinal stem cell model findings into practical dosing, controls, readouts, and troubleshooting strategies.
-
Clarithromycin CYP3A Inhibitor Workflows
2026-08-25
Build more interpretable drug-drug interaction research with Clarithromycin, a practical CYP3A inhibitor for controlled metabolism and pharmacokinetic studies. This guide combines solvent handling, concentration design, pathway controls, and troubleshooting for statin and cardiovascular disease drug interaction models.
-
Toremifene Citrate: ER Assay Workflow Guide
2026-08-25
Build more interpretable estrogen receptor experiments with a concentration-aware workflow for receptor binding, MCF-7 proliferation, and pathway analysis. This guide combines practical assay controls with comparative insight from the toremifene-versus-tamoxifen evidence base.
-
TUNEL Apoptosis Detection Kit for Glioma Studies
2026-08-24
Learn how to apply DAB-based TUNEL staining to cultured glioma cells and tissue sections, connecting DNA fragmentation with treatment response and tissue morphology. The workflow combines practical controls, optimization guidance, and a glioma-focused interpretation framework based on recent network pharmacology and experimental findings.
-
HyperScript™ Reverse Transcriptase for RNA Assays
2026-08-24
Learn how HyperScript™ Reverse Transcriptase can strengthen RNA to cDNA conversion when adipose-tissue transcripts are long, structured, or scarce. This article translates new Netrin-1 biology into practical cDNA synthesis for qPCR and assay-validation decisions.
-
GSK126 and the Next Generation of EZH2 Translation
2026-08-23
A translational framework for using GSK126 to connect PRC2 biology, H3K27me3 pharmacodynamics, cancer epigenetics research, and emerging EZH2 degradation insights.
-
Annexin V-APC/7-AAD Apoptosis Kit Guide
2026-08-22
The Annexin V-APC/7-AAD Apoptosis Kit connects phosphatidylserine exposure with membrane-integrity analysis for rigorous apoptosis and necrosis detection. This guide explains how to interpret the assay alongside mechanistic studies of epigenetic drug response, including MLL-rearranged leukemia research.
-
Rosiglitazone: Designing Better Adipose Assays
2026-08-21
Rosiglitazone and Brl-49653 provide a precise way to interrogate PPARγ biology. This guide develops a comparative assay framework that separates adipogenesis, insulin sensitivity modulation, and beige-fat thermogenesis using recent SEMA3E research.
-
SR 11302: AP-1 Transcription Factor Inhibitor Guide
2026-08-20
SR 11302 enables selective interrogation of AP-1-driven proliferation, tumor promotion, and macrophage-associated cancer biology without activating retinoid receptors. This practical guide connects cell-based dose–response assays with the TLR4–macrophage framework reported in colitis-associated colorectal cancer research.
-
Engineered Klotho mRNA Reverses Senescence in iMSCs
2026-08-20
The reference study combines engineered, non-integrating Klotho mRNA with hyperbranched poly(β-amino ester) delivery to address senescence in Klotho-deficient and aged induced mesenchymal stem cells. Its findings connect restored Klotho expression with improved mitochondrial function, reduced oxidative stress, normalized calcium homeostasis, and selective recovery of older or Klotho-deficient cells.
-
Adipose–Neural Signaling in Cardiac Arrhythmia
2026-08-19
Fan et al. developed a stem cell-based coculture model showing that epicardial adipocyte-derived leptin activates sympathetic neurons, increases neuropeptide Y release, and promotes cardiomyocyte arrhythmia through Y1R, NCX, and CaMKII signaling. Patient observations linking greater epicardial adipose tissue thickness with higher leptin and NPY levels support the model’s clinical relevance and identify experimentally testable intervention points.